It was therefore of interest to study in vitro i) how Rac1b controls tumour cell responses to TGF-β that are associated with malignant conversion such as EMT and cell migration/invasion and ii) which signalling pathways are targetted by Rac1b. This evidence concerns the gene TGFB1 and neoplasm.